Ventyx Biosciences Inc (NASDAQ:VTYX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Sheila Gujrathi Other companies: Bolt Biotherapeutics, Inc. (Chief Strategy Officer · Since at least Oct 23, 2026); BlossomHill Therapeutics, Inc. (Director · Since at least Aug 6, 2026); Processa Pharmaceuticals, Inc. (Director · Since at least Jul 28, 2026); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Turning Point Therapeutics Inc (Director · Apr 16, 2019 – Jun 15, 2020 · Past); Gossamer Bio, Inc. (President & CEO, Director · Feb 7, 2019 – Feb 14, 2020 · Past); Five Prime Therapeutics Inc (Director · Dec 2, 2015 – May 10, 2018 · Past); Receptos Inc (Chief Medical Officer · May 8, 2013 – Aug 25, 2015 · Past) | Director · Since at least Oct 20, 2021 |
| Onaiza Cadoret-Manier Other companies: Ardelyx, Inc. (Director · Since at least Mar 12, 2020); Ionis Pharmaceuticals, Inc. (EVP,Chf GL Pdt Str & Oper Ofc · Jan 9, 2020 – Feb 2, 2024 · Past) | Director · Since at least Jan 11, 2023 |
| William Richard White Other companies: Disc Medicine, Inc. (Director · Since at least Jun 11, 2025); Akero Therapeutics Inc (Chief Financial Officer · Since at least Jun 10, 2025) | Director · Since at least Jun 5, 2025 |
| Mark S Forman Other companies: Passage Bio, Inc. (CHIEF MEDICAL OFFICER · Mar 30, 2022 – Mar 15, 2024 · Past) | Chief Medical Officer · Since at least Aug 12, 2024 |
| Matthew Richard Moore Other companies: Arcutis Biotherapeutics, Inc. (SVP and Chief Business Officer · Jan 11, 2021 – May 1, 2024 · Past) | Chief Operating Officer · Since at least May 16, 2024 |
| Richard Gaster Other companies: Elevation Oncology Inc (Director · Jun 24, 2021 – Jun 24, 2021 · Past) | Director · Oct 20, 2021 – Jun 9, 2022 · Past |
| Somu Subramaniam Other companies: icad inc (Director · Dec 30, 2010 – Sep 28, 2018 · Past) | Director · Since at least Oct 20, 2021 |
| Allison Hulme | Director · Since at least Jan 11, 2023 |
| Christopher W Krueger | CHIEF BUSINESS OFFICER · Oct 20, 2021 – Apr 2, 2024 · Past |
| John Nuss | CHIEF SCIENTIFIC OFFICER · Since at least Oct 20, 2021 |
| Martin Auster | CHIEF FINANCIAL OFFICER · Oct 20, 2021 – Apr 2, 2024 · Past |
| Raju Mohan | CEO AND PRESIDENT, Director · Since at least Oct 20, 2021 |
| Roy Gonzales | Senior VP, Finance · Since at least Aug 30, 2024 |